BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 17405070)

  • 21. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis.
    Barben J; Ammann RA; Metlagel A; Schoeni MH;
    J Pediatr; 2005 Feb; 146(2):183-8. PubMed ID: 15689903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sweat-testing: a review of current technical requirements.
    Beauchamp M; Lands LC
    Pediatr Pulmonol; 2005 Jun; 39(6):507-11. PubMed ID: 15830391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sweat test: effect of elution time on chloride and sodium concentrations.
    Gilbert CJ; Griffiths MJ; Holland MR; Gama R
    Ann Clin Biochem; 2005 Sep; 42(Pt 5):400-1. PubMed ID: 16168198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnosis of cystic fibrosis in Indian patients--a preliminary report.
    Ashavaid TF; Dherai AJ; Kondkar AA; Raghavan R; Udani SV; Udwadia ZF; Desai D
    J Assoc Physicians India; 2003 Apr; 51():345-8. PubMed ID: 12723646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control.
    Sands D; Ołtarzewski M; Nowakowska A; Zybert K
    Folia Histochem Cytobiol; 2010 Sep; 48(3):358-65. PubMed ID: 21071339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A reference interval for sweat chloride in infants aged between five and six weeks of age.
    Jayaraj R; Barton PV; Newland P; Mountford R; Shaw NJ; McCarthy E; Isherwood DM; Southern KW
    Ann Clin Biochem; 2009 Jan; 46(Pt 1):73-8. PubMed ID: 19103961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sweat testing for cystic fibrosis: standards of performance in Australasia.
    Coakley J; Scott S; Mackay R; Greaves R; Jolly L; Massie J; Mishra A; Bransden A; Doery JC; Chiriano A; Robins H
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):332-7. PubMed ID: 19487411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis of mucoviscidosis by examination of sweat: value of conductometry].
    Sprössig C; Wunderlich P; Bergmann S; Hoffmann C
    Kinderarztl Prax; 1989 Oct; 57(10):497-502. PubMed ID: 2601268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis.
    Hammond KB; Turcios NL; Gibson LE
    J Pediatr; 1994 Feb; 124(2):255-60. PubMed ID: 8301433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing?
    Mackay RJ; Florkowski CM; George PM; Sies CW; Woods S
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):535-8. PubMed ID: 18941126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
    Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM
    J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sweat conductivity test: can it replace chloride titration for cystic fibrosis diagnosis?
    Cinel G; Doğru D; Yalçın E; Özçelik U; Gürcan N; Kiper N
    Turk J Pediatr; 2012; 54(6):576-82. PubMed ID: 23692782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current use of the sweat test (author's transl)].
    Götz M; Stur O
    Padiatr Padol; 1977; 12(4):413-6. PubMed ID: 904949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis: an improved diagnostic method utilizing constant current iontophoresis.
    Palombini BC; Souza PR
    Rev Bras Biol; 1972 Aug; 32(2):197-204. PubMed ID: 4651864
    [No Abstract]   [Full Text] [Related]  

  • 36. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between sweat chloride, sodium, and age in clinically obtained samples.
    Traeger N; Shi Q; Dozor AJ
    J Cyst Fibros; 2014 Jan; 13(1):10-4. PubMed ID: 23916616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sweat conductivity and coulometric quantitative test in neonatal cystic fibrosis screening.
    Domingos MT; Magdalena NI; Cat MN; Watanabe AM; Rosário Filho NA
    J Pediatr (Rio J); 2015; 91(6):590-5. PubMed ID: 26092226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of sweat testing in North America. Results of the College of American Pathologists needs assessment survey.
    LeGrys VA; Burnett RW
    Arch Pathol Lab Med; 1994 Sep; 118(9):865-7. PubMed ID: 8080353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A; Koscik RL; Farrell PM; Rock MJ
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.